Adams, D., Suhr, O. B., Dyck, P. J., Litchy, W. J., Leahy, R. G., Chen, J., . . . Coelho, T. (2017). Trial design and rationale for APOLLO, a Phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy. BMC neurology, 17(1), 181-12. https://doi.org/10.1186/s12883-017-0948-5
Citace podle Chicago (17th ed.)Adams, David, Ole B. Suhr, Peter J. Dyck, William J. Litchy, Raina G. Leahy, Jihong Chen, Jared Gollob, a Teresa Coelho. "Trial Design and Rationale for APOLLO, a Phase 3, Placebo-controlled Study of Patisiran in Patients with Hereditary ATTR Amyloidosis with Polyneuropathy." BMC Neurology 17, no. 1 (2017): 181-12. https://doi.org/10.1186/s12883-017-0948-5.
Citace podle MLA (9th ed.)Adams, David, et al. "Trial Design and Rationale for APOLLO, a Phase 3, Placebo-controlled Study of Patisiran in Patients with Hereditary ATTR Amyloidosis with Polyneuropathy." BMC Neurology, vol. 17, no. 1, 2017, pp. 181-12, https://doi.org/10.1186/s12883-017-0948-5.